Research funder · United States
American Cancer Society
Health organization seeking to cure and treat cancer
- Grants since 2016
- 2 163
- Awarded, last 5 years (where amounts are published)
- 648.5M
- Funded works, last 5 years
- 5 405
- Funded works, all time
- 33.1k
Grants
2022–2025 · award
Role of FBH1 helicase in maintaining genome stability
2022–2025 · award
Exploiting paralog synthetic lethality for cancer therapy
2022–2026 · award
Targeting cancer stem cells to induce anti-tumor immunity in small cell lung cancer
Esra Akbay · The University of Texas Southwestern Medical Center
2022–2025 · award
Examining Obesity-Associated Inflammation in Breast Cancer Recurrence
2022–2025 · award
Physiologic medium to investigate conditionally essential genes in human cancer cells
2022–2025 · award
Determining the contribution of TPr to platelet-mediated metastasis
Thomas Werfel · University of Mississippi
2022 · award
Understanding estrogen-driven breast tumorigenesis in invasive lobular carcinoma
2022–2023 · award
Mechanisms of dendritic cell cancer surveillance during lung metastasis
2022–2025 · award
Understanding the Effect of Out-of-Pocket Costs in Cancer Care
Arden Morris · The Board Of Trustees Of The Leland Stanford Junior University
2022–2026 · award
Pre- and Post-Diagnosis Metformin Use and Ovarian Cancer Survival
2022–2026 · award
FIA-Charles R. Drew University of Medicine and Science
2022–2026 · award
You are Fostering Innovation Award for ACS Professors (Howard)
2022–2025 · award
EZH2-mediated epigenetic reprogramming of ovarian cancer stroma
2022–2024 · award
Tumor/normal genomic profiling to identify and characterize pathogenic germline variants in metastatic cancer
2022–2026 · award
Hepatic stellate cells in liver cancer
2022–2026 · award
Protein Homeostasis Network Regulates Oncogenic Signaling in High-Grade Serous Ovarian Cancer
2022–2027 · award
Therapeutic targeting deubiquitinase BAP1 in human small cell lung cancer
2022–2024 · award
Institutional Research Grant
2022–2026 · award
Novel Chemical Tools for Discovery of lung Cancer-Specific Biomarkers
2022–2023 · award
Label-free, multi-scale imaging for improved detection of peritoneal metastasis
2022–2027 · award
Clinical Research Professors
2022 · award
Phosphoinositide Regulation of The Hippo Pathway
Brooke Emerling · Sanford Burnham Prebys Medical Discovery Institute
2022–2026 · award
Exploiting macropinocytosis in gastrointestinal cancer
Wantong Yao · The University of Texas Health Science Center at Houston
2022–2024 · award
Early Palliative Care Following Aborted Cancer Surgery: Characterizing and Addressing Patient Needs
2022–2024 · award
Institutional Research Grant
2022–2025 · award
Financial Worry about Affording Healthcare in Breast Cancer
2022–2025 · award
Hospitals in Accountable Care Organizations and Cancer Quality and Costs
2022–2024 · award
Dissecting the molecular pathogenesis of pediatric glioblastoma
2022–2025 · award
Preclinical Validation of Personalized Molecular Assays for Measurable Residual Disease Monitoring in Pediatric AML
2022–2023 · award
Precision targeting of the labile iron pool for cancer theranostics
2022 · award
Investigating Disparities in Metastatic Pancreatic Cancer: Effect of Treatment Type and Therapeutic Delays on Survival
2022–2024 · award
Advancing a Self-Collected Urine Test to Improve Patient Access for HPV+ HNSCC Surveillance
2022–2024 · award
Genetic determinants of immune evasion by metastatic lung cancer
2022 · award
Structural Analysis of Oncogenic Human Retroviral Assembly
2022–2024 · award
Uncovering the Germline Genetic Program
Sherilyn Grill · Whitehead Institute for Biomedical Research
2022–2025 · award
Institutional Research Grant
Andrew Chapman · Thomas Jefferson University
2022–2025 · award
Sentinel Node Immune Signatures & Outcome in Triple Negative Breast Cancer
2022 · award
Disparities in Use, Toxicity, and Efficacy of Oral Antineoplastic Drugs in Patients with Advanced Breast Cancer
Dawn Hershman · The Trustees Of Columbia University In The City Of New York
2022–2025 · award
Wearable biosensors for point of care personalization of cancer drugs
2022–2024 · award
Institutional Research Grant
Robin J. Leach · The University of Texas at San Antonio Health Science Center